Orthox Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 11

Orthox General Information

Description

Developer of tissue regenerative implants intended to address large injuries to knee cartilage in which early osteoarthritis may be present. The company's tough, resilient, low-friction, hydrogel implants emulate cartilage tissue and rapidly restore knee function while allowing the body's cells to grow through and integrate with the device, enabling patients to return to a fully active and pain-free lifestyle.

Contact Information

Website
www.orthox.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Services
Corporate Office
  • 66 Innovation Drive
  • Milton Park
  • Oxfordshire OX14 4RQ
  • England, United Kingdom
+44 01235 000000

Orthox Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orthox Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
20. Secondary Transaction - Private 30-Jan-2024 000.00 Completed Clinical Trials - General
19. Later Stage VC (Series A) 09-Feb-2022 000.00 000.00 000.00 Completed Clinical Trials - General
18. Accelerator/Incubator 30-May-2021 00000 000.00 Completed Clinical Trials - Phase 1
17. Later Stage VC 01-Dec-2020 00000 000.00 Completed Pre-Clinical Trials
16. Later Stage VC 01-Sep-2020 00000 000.00 Completed Clinical Trials - Phase 1
15. Grant 01-Jul-2020 00.000 0000 Completed Clinical Trials - Phase 1
14. Grant 09-Oct-2019 00.000 0000 Completed Clinical Trials - Phase 1
13. Grant 01-Jan-2020 00000 0000 Completed Clinical Trials - General
12. Grant 01-Oct-2019 $120K $11M Completed Clinical Trials - General
11. Grant 01-Oct-2018 $1.57M $11M Completed Clinical Trials - General
To view Orthox’s complete valuation and funding history, request access »

Orthox Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 000.00 000.00 000.00 00.000
Ordinary 00,000 00.000000 000.00 000.00 000.00 0.000
To view Orthox’s complete cap table history, request access »

Orthox Patents

Orthox Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201708909-D0 Implantable tissue repair devices and methods for manufacturing the same Inactive 05-Jun-2017 00000000000
US-20200205986-A1 Implantable tissue repair devices and methods for manufacturing the same Inactive 05-Jun-2017 00000000000 0
AU-2018281970-A1 Implantable tissue repair devices and methods for manufacturing the same Active 05-Jun-2017 00000000000
EP-3634318-B1 Methods for manufacturing implantable tissue repair devices Active 05-Jun-2017 00000000000
EP-3634318-A1 Implantable tissue repair devices and methods for manufacturing the same Active 05-Jun-2017 A61F2/30756
To view Orthox’s complete patent history, request access »

Orthox Executive Team (4)

Name Title Board Seat Contact Info
Nicholas Skaer Ph.D Co-Founder, Chief Scientist, Chief Executive Officer, Research Director & Board Member
Robert Walker Ph.D Chief Scientific Officer & Product Development Manager
Oliver Kessler MD Co-Founder, Medical Director & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

Orthox Board Members (10)

Name Representing Role Since
Allan Ritchie Orthox Board Member 000 0000
Don Haut Self Chairman 000 0000
Friedrich Vollrath Self Board Member 000 0000
James Mallinson Oxford Investment Consultants Board Member 000 0000
Neil Cameron Parkwalk Advisors Board Observer & Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Orthox Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Orthox Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Additio Investment Group Venture Capital Minority 000 0000 000000 0
MedTech Innovator Accelerator/Incubator 000 0000 000000 0
Perivoli Innovations Trust Venture Capital Minority 000 0000 000000 0
AtmosClear Investments Venture Capital Minority 000 0000 000000 0
EIT Health Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Orthox FAQs

  • When was Orthox founded?

    Orthox was founded in 2008.

  • Who is the founder of Orthox?

    Nicholas Skaer Ph.D and Oliver Kessler MD are the founders of Orthox.

  • Who is the CEO of Orthox?

    Nicholas Skaer Ph.D is the CEO of Orthox.

  • Where is Orthox headquartered?

    Orthox is headquartered in Oxfordshire, United Kingdom.

  • What is the size of Orthox?

    Orthox has 22 total employees.

  • What industry is Orthox in?

    Orthox’s primary industry is Therapeutic Devices.

  • Is Orthox a private or public company?

    Orthox is a Private company.

  • What is Orthox’s current revenue?

    The current revenue for Orthox is 00000.

  • How much funding has Orthox raised over time?

    Orthox has raised $24.4M.

  • Who are Orthox’s investors?

    Additio Investment Group, MedTech Innovator, Perivoli Innovations Trust, AtmosClear Investments, and EIT Health are 5 of 11 investors who have invested in Orthox.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »